Mangalam Drugs & Organics Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Mangalam Drugs & Organics Ltd · Outcome · 06 Nov 2026, 12:01 am
Mangalam Drugs & Organics Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 7,939 (+61.2% YoY | +39.0% QoQ) ■ EBITDA: -115 (+63.1% YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -1.5 (+488 bps YoY | Profit to Loss QoQ) ■ PAT: -721 (+1.9% YoY | +5.6% QoQ) ■ EPS (INR): -4.55 (+1.9% YoY | +5.8% QoQ)
Original exchange filing (PDF)
More announcements from Mangalam Drugs & Organics Ltd
- Subsequent Intimation of Bank Deafult in Pursuant to Regulation 30 Para A of SEBI (LODR), 2015 · 16 Nov 2026
- Subsequent Intimation of Bank Deafult in Pursuant to Regulation 30 Para A of SEBI (LODR), 2015 · 16 Nov 2026
- Mangalam Drugs And Organics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 06 Nov 2026
- Intimation under Regulation 36(1)(b) of SEBI (LODR) Regulations, 2015 - Dispatch of Letter for Non- Email Cases · 04 Nov 2026
- Intimation for members consent received under Regulation 30 of SEBI (LODR), 2015 for appointment of Mr. Prabhakar Zavar as an Independent Director wef. September 15 2026 for term of 5 years, .... · 02 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 05 Nov 2026
- MANGALAM DRUGS AND ORGANICS LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 05 Nov 2026
- MANGALAM DRUGS AND ORGANICS LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 05 Nov 2026
